eConsent in Healthcare Market - Forecasts from 2023 to 2028

The global eConsent in healthcare market was valued at US$405.431 million in 2021.

The eConsent in healthcare market is anticipated to grow at a steady pace throughout the forecast period. The process of getting a patient's informed permission electronically in the healthcare sector is referred to as eConsent. It entails presenting information to patients regarding medical procedures, treatments, research projects, or other healthcare interventions through electronic technologies, such as software apps or internet platforms, and allowing them to electronically give their consent. Multiple associated benefits and increased digitalization in healthcare are major growth drivers of eConsent in healthcare market. Moreover, the technological advancements and favourable government regulations resulting in more product launches and adoption of eConsent are also contemplated to augment the eConsent in healthcare market.

Multiple Associated Benefits

There are multiple benefits associated with eConsent that are contemplated to boost the eConsent in healthcare market. Interactive elements are frequently included in eConsent platforms to improve patient comprehension and involvement. Healthcare organizations can save time, money, and resources by digitizing the permission process instead of printing, storing, and managing paper consent forms. Electronic health record (EHR) systems and eConsent platforms frequently work together to provide seamless documentation and retrieval of consent data, saving time and resources. Moreover, the use of eConsent streamlines the remote consent procedure by enabling patients to electronically sign consent forms from the comfort of their homes, eliminating the need for office visits and paperwork.

Increased Implementation of Digital Technology

The healthcare sector has been going through a digital revolution, with a growing emphasis on using technology to improve patient care and expedite processes. By substituting electronic technologies for paper-based consent forms, eConsent supports this shift by enabling healthcare organizations to digitize and automate the consent process thereby boosting the eConsent in healthcare market. WHO launched a Global Strategy on Digital Health 2020-2025 in March 2019 to address major issues facing the health system, the global plan encourages the appropriate use of digital technologies as digital public goods that may be customized for usage in various situations to provide equitable access to digital resources. Moreover, in June 2023, a historic partnership between the European Commission and the World Health Organization (WHO) was announced to provide a variety of digital items to improve everyone's health.

Favourable Government Regulations

The government of numerous nations is promoting digitalization in the healthcare industry including eConsent which is propelling the eConsent in healthcare market. For example, to provide recommendations on the use of electronic systems and processes that may employ multiple electronic media to obtain informed consent for HHS-regulated human subjects research and FDA-regulated clinical investigations, the FDA, in cooperation with HHS and OHRP, published a guideline for the use of eConsent in clinical investigations.

Efficiency in Clinical Trials

The adoption of eConsent in clinical trials is booming due to its efficiency in collecting patient preferences, and comprehension therefore it propels the eConsent in healthcare market. According to Signant Health's 2019 Industry eConsent Survey, 65% of CRO respondents and 85% of sponsor respondents said to adopt eConsent for some studiens in the next 12 months while 76% of CRO and 71% of sponsor respondents reported the adoption of eConsent in the majority of studies in the coming 3 years and beyond. The most popular business driver in the adoption of eConsent in clinical trials according to this survey was patient comprehension and engagement with 91% of overall votes.

Restraints in the Market

Few factors are expected to limit eConsent in healthcare market. For example, electronic health records (EHRs) and clinical trial management systems must be compatible to implement eConsent and it may be difficult for healthcare organizations to integrate eConsent platforms with their current IT infrastructure. The eConsent's reliance on outside vendors for design and programming can prolong the time it takes to deploy and go live. Moreover, it may be difficult for older folks, people with low levels of computer literacy, or members of underprivileged populations to comprehend and use eConsent systems. The design of eConsent systems must incorporate accessibility elements and offer patients who might need assistance or prefer non-digital consent methods alternate options.

North America is Expected to Grow Significantly

The North American region is projected to hold a significant share of the eConsent in healthcare market. Various factors attributed to such a share are higher adoption of digital technology in healthcare, increased clinical trials, and well-established healthcare facilities. For instance, North America was the most popular region with a higher implementation rate (72%) of eConsent as per the 2019 Industry eConsent Survey by Signant Health. Moreover, the presence of major market players such as Veeva Systems, and Florence Healthcare are also expected to boost the eConsent in healthcare market through enhanced accessibility and easy adoption of eConsent in the region.

Major Market Players

• Veeva Systemsis a cloud-based software provider with a focus on offering technological solutions to the medical sciences sector. Life sciences organizations can manage their regulated material using the cloud-based content management tool Veeva Vault. Moreover, Veeva OpenData offers complete and verified information on healthcare organizations and professionals.
• Florence Healthcare,founded in 2014, provides a platform for managing electronic document workflows that is especially suited for clinical research. The Florence eBinders platform offers a cloud-based solution for managing electronic Trial Master Files (eTMFs) and Investigator Site Files (eISFs).
• Wellbeing Software, (Citadel Group)is an organization that specializes in delivering software solutions and services to facilitate the administration of clinical information and enhance patient outcomes. Patient records from various organizations are connected through Stratus Shared Records developed by the company

Key Market Developments

• In November 2022,YPrime launched the eConsent platform to enable study teams to present increasingly complex study information to patients in highly navigable, digestible components that improve comprehension and boost engagement.
• In January 2022,SMART-TRIAL released a new eConsent Add-On to enable the collection of consents with full control of the setup.
• In July 2021,Castor launched scalable patient enrollment and the eConsent platform to enhance the current patient enrollment process and higher study engagement.

Segmentation:

By Platform

• Cloud-based
• Web-based

By Enrollment Type

• On-site
• Remote

By Form Type

• General Consent
• General Consent with Specific Denial(s)
• General Denial with Specific Consent(s)
• General Denial

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others